PmcKwd.i
Checkpoint
Pmc
Racine
Checkpoint
Pmc
Exploration
Accueil
Racine
Racine

Serveur d'exploration SRAS - Checkpoint (Pmc)

Index « PmcKwd.i » - entrée « Vaccine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Vaccination trends < Vaccine < Vaccine Candidate  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
000467 (2019) Fatima Abdirizak ; Rayleen Lewis ; Gerardo ChowellEvaluating the potential impact of targeted vaccination strategies against severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks in the healthcare setting
000478 (2019) Lin Yang ; King Pan Chan ; Chit Ming Wong ; Susan Shui Seng Chiu ; Ricardo J. Soares Magalhaes [Australie] ; Thuan Quoc Thach ; Joseph Syrial Malik Peiris ; Archie C. A. Clements [Australie] ; Wenbiao Hu [Australie]Comparison of influenza disease burden in older populations of Hong Kong and Brisbane: the impact of influenza and pneumococcal vaccination
000668 (2016) William J. Liu [République populaire de Chine] ; Min Zhao [République populaire de Chine] ; Kefang Liu [République populaire de Chine] ; Kun Xu [République populaire de Chine] ; Gary Wong [République populaire de Chine] ; Wenjie Tan [République populaire de Chine] ; George F. Gao [République populaire de Chine]T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
000862 (2014) Christopher M. Coleman [États-Unis] ; Ye V. Liu [États-Unis] ; Haiyan Mu [États-Unis] ; Justin K. Taylor [États-Unis] ; Michael Massare [États-Unis] ; David C. Flyer [États-Unis] ; Gregory M. Glenn [États-Unis] ; Gale E. Smith [États-Unis] ; Matthew B. Frieman [États-Unis]Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
000966 (2013) Lu Lu [République populaire de Chine] ; Qi Liu [République populaire de Chine] ; Lanying Du [États-Unis] ; Shibo Jiang [République populaire de Chine, États-Unis]Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread
000981 (2013) Rolf Hilgenfeld [Allemagne] ; Malik Peiris [République populaire de Chine]From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses
000B05 (2011) Kai Zhao ; Hui Wang ; Changyou WuThe immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8+ T cells are augmented in varying degrees by CpG ODN, PolyI:C and R848
000C22 (2010) Jason Netland [États-Unis] ; Marta L. Dediego [Espagne] ; Jincun Zhao [États-Unis] ; Craig Fett [États-Unis] ; Enrique Álvarez [Espagne] ; José L. Nieto-Torres [Espagne] ; Luis Enjuanes [Espagne] ; Stanley Perlman [États-Unis]Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease
000E37 (2008) D. Cavanagh ; P. BrittonCoronaviruses: General Features
000F56 (2007) Lei Ba ; Christopher E. Yi ; Linqi Zhang ; David D. Ho ; Zhiwei ChenHeterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus
000F61 (2007) Seraphin Kuate [Allemagne] ; Jindrich Cinatl [Allemagne] ; Hans Wilhelm Doerr [Allemagne] ; Klaus Überla [Allemagne]Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies
001108 (2006) Koji Ishii [Japon] ; Hideki Hasegawa [Japon] ; Noriyo Nagata [Japon] ; Tetsuya Mizutani [Japon] ; Shigeru Morikawa [Japon] ; Tetsuro Suzuki [Japon] ; Fumihiro Taguchi [Japon] ; Masato Tashiro [Japon] ; Toshitada Takemori [Japon] ; Tatsuo Miyamura [Japon] ; Yasuko Tsunetsugu-Yokota [Japon]Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs
001342 (2005) Markus Czub [Canada] ; Hana Weingartl [Canada] ; Stefanie Czub [Canada] ; Runtao He [Canada] ; Jingxin Cao [Canada]Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
001405 (2005) Ali Azizi ; Susan Aucoin ; Helina Tadesse ; Rita Frost ; Masoud Ghorbani ; Catalina Soare ; Turaya Naas ; Francisco Diaz-MitomaA combined nucleocapsid vaccine induces vigorous SARS-CD8+ T-cell immune responses
001546 (2004) Yuxian He [États-Unis] ; Yusen Zhou [République populaire de Chine] ; Shuwen Liu [États-Unis] ; Zhihua Kou [République populaire de Chine] ; Wenhui Li [États-Unis] ; Michael Farzan [États-Unis] ; Shibo Jiang [États-Unis]Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine
001629 (2004) Yuxian He [États-Unis] ; Yusen Zhou [République populaire de Chine] ; Pamela Siddiqui [États-Unis] ; Shibo Jiang [États-Unis]Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry
001892 (2003) Anne S. De GrootHow the SARS vaccine effort can learn from HIV—speeding towards the future, learning from the past

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Pmc/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/PmcKwd.i -k "Vaccine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/PmcKwd.i  \
                -Sk "Vaccine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Pmc
   |étape=   Checkpoint
   |type=    indexItem
   |index=    PmcKwd.i
   |clé=    Vaccine
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021